REGENEUS LTD (ASX:RGS)
Industry: Classification Pending
Activity: Regenerative medicine.
25 Bridge Street PYMBLE NSW 2073
Ph: (02) 9499 8010    Fax: (02) 9499 8020
Duncan Thomson
Wed, 13 Nov 2013 1:30pm
Duncan Thomson, Head of Animal Health
Icon_lastIcon_nextIcon_previousIcon_first
Interim Results
Thu, 19 Feb 2015
Annual General Meeting
Tue, 28 Oct 2014
Full Year Results
Mon, 25 Aug 2014
Interim Results
Thu, 27 Feb 2014
Annual General Meeting
Wed, 27 Nov 2013
Appendix 3Y - Dr Roger Aston Thu, 4 Jun 2015
Approval for personalised cancer immunotherapy trial Mon, 25 May 2015
Appendix 4C - quarterly Wed, 29 Apr 2015
Regeneus receives approval for Progenza OA trial Wed, 22 Apr 2015
Achievement of key stem cell manufacturing milestone Tue, 7 Apr 2015
Appendix 3X - Dr Glen Richards Wed, 1 Apr 2015
RGS to present at Regenerative Medicine Investor Day Mon, 23 Mar 2015
Positive preclinical results for Progenza Mon, 9 Mar 2015
New Director joins Regeneus Board of Directors Mon, 23 Feb 2015
Regeneus Half-Yearly Appendix 4D and Accounts Thu, 19 Feb 2015

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.